The Pump That Will Revolutionize the World of Cardiac Surgery
Puzzle Medical Devices is the brainchild first developed during an entrepreneurship course at ÉTS in 2018—and it has sure come a long way ever since! The company’s flagship medical device, a minimally invasive cardiac pump, received its first Food and Drug Administration (FDA) approval in January 2021.This success boils down to the hard work of the company’s three co-founders: Jade Doucet-Martineau, an ÉTS mechanical engineering graduate, who co-founded the company with François Trudeau, an ÉTS robotic engineering graduate, and Dr. Gabriel Georges, now a cardiac surgeon at the Québec Heart and Lung Institute (IUCPQ). The three young students had to overcome many obstacles along the way, not least of which was being taken seriously.
Clearly, the company has proven that it’s the real deal! Investors from Canada, the United States, and Europe came knocking on their door, and a world-renowned interventional cardiologist joined the team as Medical Chief.
The heart pump designed by these three young entrepreneurs now stands as a beacon of hope for the 26 million patients worldwide who struggle with heart failure.